FLUIDS iQ recently expanded our line of Intestinal iQ™ tests with the inclusion of Candida albicans as a testing option, either alone or in combination with others in our Intestinal iQ™ family of wellness tests.

But why Candida, you might ask?

As we know, Candida is a yeast naturally found in the gut. A healthy microbiome is able to keep opportunistic Candida in check. When the microbiome becomes dysbiotic, however, Candida can quickly spread throughout the body, leading to many issues, including increased intestinal permeability and inflammation1.

Many people go through life with intestinal permeability and chronic inflammation and never really understand what factors could be underlying these situations. They may develop Candida overgrowth, which can create very significant inflammatory spirals that, in turn, may contribute to damage in their joints, brain tissue, skin and other organ systems2.

A neglected or undetected infection with Candida albicans, as well as other pathogenic yeasts, have been linked to problems such as chronic fatigue3,autism4, multiple sclerosis5 and depression6. The use of antibiotics, oral contraceptives, chemotherapy, and anti-inflammatory steroids greatly increase susceptibility to Candida7.

Candida overgrowth produces toxins that can increase permeability in the intestinal lining. Moreover, with subsequent entry into the blood stream, Candida can cause an inflammatory immune system response7.

FLUIDS iQ’s new test for Candida is called the “Candida Suite” – testing for the three immunoglobulin to Candida albicans, namely IgM, IgG and IgA. It is offered as a standalone test or as an add-on to any of our Intestinal iQ tests.

Testing for the Candida immunoglobulins identifies the immune provoking agents, a first step that will lead to their elimination from the diet. In turn, this reduces inflammation in the body and quiets down the hyperactive immune system. When combined with gut healing, the intestine is able to heal.

We added Candida to our growing line of Intestinal iQ™ analytical tests because we firmly believe it serves to broaden the portrait of intestinal status.

References:
1. Kumamoto, C. Inflammation and gastrointestinal Candida colonization.CurrOpinMicrobiol. 2011; 14: 386-391.
2. Galland, L. Nutrition and Candidiasis. J of Orthomolecular Psychiatry. 1983; 14: 50-60.
3. Stewart DE. Emotional Disorders Misdiagnosed as Physical Illness: Environmental Hypersensitivity, Candidiasis Hypersensitivity, and Chronic Fatigue Syndrome. International Journal of Mental Health. 1990; 19: 56-68.
4. Hughes HK and Ashwood P.Anti-Candida albicans IgG Antibodies in Children With Autism Spectrum Disorders. Frontiers in Psychiatry. 2018; 9: 1-5.
5. Benito-León J, Pisa D, Alonso R, Calleja P,Díaz-Sánchez M et al. Association between multiple sclerosis and Candida species: evidence from a case-control study. European Journal of Clinical Microbiology and Infectious Diseases. 2010; 29: 1139-1145.
6. Rucklidge JJ. Could yeast infections impair recovery from mental illness? A case study using micronutrients and olive leaf extract for the treatment of ADHD and depression. Adv Mind Body Med. 2013; 27: 14-18.
7. Miranda LN et al. Candida colonisation as a source for candidaemia. J Hosp Infect. 2009; 72: 9–16.